KEYNOTE-045 – pembrolizumab as second-line treatment in urothelial carcinoma
Is robotic surgery better for muscle invasive bladder cancer?
How effective is pembrolizumab in cisplatin-ineligible bladder cancer? Results from KEYNOTE-052
Treating advanced/metastatic urothelial carcinoma: recent developments in the BGJ398 clinical trial
BISCAY trial for bladder cancer - trial design and its potential impact on clinical practice